Tag: endovascular stent grafts market players

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Endovascular Stent Grafts Market Size And Revenue Outlook Through 2030

The market for endovascular stent grafts has undergone considerable expansion in recent years. Its value is projected to climb from $1.45 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 37.9%. The historical growth of this market stems from factors such as the continued reliance on traditional open surgical procedures, the restricted supply of sophisticated stent graft materials, the escalating occurrence of vascular diseases, the swift uptake of coronary and peripheral grafts, and heightened public knowledge about aortic aneurysm treatments.

The endovascular stent grafts market is projected to experience substantial growth over the coming years. Its size is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This expansion during the projection period is driven by factors such as advancements in endovascular stent graft technology, an increase in minimally invasive surgical procedures, a rise in cases of aortic aneurysm and dissection, the growing acceptance of hybrid vascular grafts, and the development of cardiovascular healthcare facilities. Key trends foreseen for this period encompass the wider embrace of minimally invasive endovascular techniques, a growing need for tailored stent grafts, innovations in hybrid and biologic graft materials, an increase in thoracic and abdominal aortic repair interventions, and a heightened emphasis on patient well-being and adherence to regulations.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=87796927&type=smp&name=Endovascular%20Stent%20Grafts%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Endovascular Stent Grafts Market Demand Drivers Opening New Revenue Streams

The rising incidence of cardiovascular diseases is expected to propel the growth of the endovascular stent graft market going forward. Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels. The increasing prevalence of cardiovascular diseases is attributable to a combination of lifestyle choices, medical conditions, genetic predisposition, and environmental factors. Endovascular stent grafts offer a valuable option for treating cardiovascular diseases with an emphasis on minimizing invasiveness and improving patient outcomes. The stent graft reinforces the weakened vessel wall, preventing it from rupturing and reducing the risk of life-threatening complications. For instance, in October 2025, according to the Australian Institute Of Health And Welfare, an Australia-based government agency reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, averaging roughly 156 incidents per day. Therefore, an increase in cardiovascular diseases drives the growth of endovascular stent grafts market.

Endovascular Stent Grafts Market Segment Outlook: Which Categories Are Growing Fastest?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Endovascular Stent Grafts Market Trends Powering Strategic Industry Growth

Leading companies within the endovascular stent grafts market are concentrating on developing novel products, such as the thoracic aortic stent-graft. Their objective is to enhance the accuracy and effectiveness of treating thoracic aortic aneurysms and dissections, improve patient recovery, and tackle intricate anatomical challenges through advanced technology and design upgrades. A thoracic aortic stent graft is a specialized medical implant utilized in endovascular procedures to address various diseases and conditions affecting the thoracic aorta, which is the segment of the aorta situated in the chest, providing safety, efficacy, and ease in managing thoracic aortic ailments. As an illustration, in February 2024, Endovastec, a medical device firm based in China, launched its Multi-Branch Thoracic Aortic Stent-Graft System, known as Hector, and completed its initial clinical application in Switzerland. The Hector system signifies a major stride forward in endovascular stent graft technology. Its innovative multi-branch configuration facilitates the treatment of complex thoracic aortic conditions by accommodating and safeguarding critical branches of the aorta, including those supplying vital organs.

Endovascular Stent Grafts Market Leading Companies And Competitive Benchmarking

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

View The Full Endovascular Stent Grafts Market Report:

https://thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Endovascular Stent Grafts Market Top Region By Revenue And Market Share

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Endovascular Stent Grafts Market Compare Between 2026 And 2030?

The market size for endovascular stent grafts has experienced substantial expansion in recent years. It is anticipated to grow from $1.45 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 37.9%. The rise observed in the historical period can be attributed to several factors including reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 37.5%. Factors contributing to this expansion during the forecast period include advancements in endovascular stent graft technology, an increase in minimally invasive surgical procedures, a rise in instances of aortic aneurysms and dissections, the growing use of hybrid vascular grafts, and the development of cardiovascular healthcare facilities. Key trends anticipated during the forecast timeframe encompass the wider acceptance of minimally invasive endovascular techniques, a heightened need for personalized stent grafts, progress in hybrid and biologic graft substances, an increase in thoracic and abdominal aortic repair interventions, and a stronger emphasis on patient safety and adherence to regulations.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Market Drivers Are Helping Shape The Endovascular Stent Grafts Market Expansion?

The burgeoning occurrence of cardiovascular diseases is anticipated to drive forward the endovascular stent graft market. Cardiovascular disease (CVD) encompasses various conditions affecting the heart or blood vessels, and its escalating prevalence stems from a mix of lifestyle habits, medical conditions, inherited predispositions, and environmental influences. Endovascular stent grafts provide a valuable intervention for treating cardiovascular ailments, prioritizing reduced invasiveness and improved patient outcomes. These stent grafts strengthen compromised vessel walls, thereby preventing rupture and diminishing the danger of severe, life-threatening complications. For example, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, reported that roughly 57,100 adults aged 25 and above suffered acute coronary events in 2023, which translates to an average of about 156 incidents daily. Therefore, an uptick in cardiovascular diseases acts as a significant catalyst for the endovascular stent grafts market’s expansion.

What Key Segment Areas Are Included In The Endovascular Stent Grafts Market Assessment?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Which Trends Are Expected To Shape The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are concentrating on developing advanced products, such as the thoracic aortic stent-graft. This effort is aimed at enhancing the precision and effectiveness of treating thoracic aortic aneurysms and dissections, ultimately improving patient outcomes, and tackling intricate anatomical challenges through sophisticated technology and design improvements. A thoracic aortic stent graft is a specialized medical device employed in endovascular surgery to address diseases and conditions of the thoracic aorta, the portion of the aorta situated in the chest, offering a combination of safety, effectiveness, and ease for managing these thoracic aortic diseases. For instance, in February 2024, Endovastec, a China-based medical device company, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and successfully performed its first clinical application in Switzerland. The Hector system represents a significant leap forward in endovascular stent graft technology. Its multi-branch design enables the treatment of complex thoracic aortic conditions by accommodating and preserving vital branches of the aorta, such as the arteries that supply essential organs.

Which Companies Form The Competitive Landscape Of The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Access The Complete Endovascular Stent Grafts Market Report:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

What Is The Largest Regional Market In The Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Endovascular Stent Grafts Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Endovascular Stent Grafts Market In 2026, And How Will Its Value Evolve By 2030?

The endovascular stent grafts market has experienced substantial growth in recent years. It is projected to increase from $1.45 billion in 2025 to $1.99 billion in 2026, at a compound annual growth rate (CAGR) of 37.9%. This historical growth can be attributed to several factors, including reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This growth during the projected timeframe stems from advancements in endovascular stent graft technology, an increase in minimally invasive surgical procedures, a rise in aortic aneurysm and dissection occurrences, greater uptake of hybrid vascular grafts, and the expansion of cardiovascular healthcare facilities. Key trends expected throughout the forecast period encompass a growing preference for minimally invasive endovascular interventions, an escalating need for tailored stent grafts, innovations in hybrid and biologic graft substances, an increase in thoracic and abdominal aortic repair operations, and a heightened emphasis on patient welfare and adherence to regulations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Primary Drivers Are Shaping The Endovascular Stent Grafts Market?

The expanding endovascular stent graft market is anticipated to grow due to the increasing prevalence of cardiovascular diseases (CVD), which are conditions affecting the heart or blood vessels. This rise in CVD cases is attributed to a combination of lifestyle choices, existing medical conditions, genetic factors, and environmental influences. Endovascular stent grafts present a valuable solution for managing cardiovascular diseases by minimizing invasiveness and improving patient results. These grafts reinforce weakened vessel walls, thereby preventing ruptures and mitigating the risk of severe complications. For example, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, indicated that an estimated 57,100 adults aged 25 and above suffered acute coronary events in 2023, averaging roughly 156 incidents daily. Thus, the escalating incidence of cardiovascular diseases is a primary driver for the growth of the endovascular stent graft market.

What Are The Key Segment Divisions In The Endovascular Stent Grafts Market Segment Structure?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

What Trends Are Affecting The Growth Of The Endovascular Stent Grafts Market?

Leading companies in the endovascular stent grafts market are concentrating on developing innovative products like thoracic aortic stent-grafts to enhance the precision and effectiveness of treating thoracic aortic aneurysms and dissections, thereby improving patient outcomes and addressing complex anatomical challenges through advanced technology and design improvements. A thoracic aortic stent graft is a specialized medical device employed in endovascular surgery to manage diseases and conditions of the thoracic aorta, the section of the aorta located in the chest, offering a combination of safety, effectiveness, and convenience for tackling thoracic aortic diseases. For instance, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its initial clinical application in Switzerland. The Hector system marks a significant advancement in endovascular stent graft technology. Its multi-branch design facilitates the treatment of complex thoracic aortic conditions by accommodating and preserving essential branches of the aorta, such as the arteries that supply vital organs.

Which Organizations Are Engaged In The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Get The Full Endovascular Stent Grafts Market Report:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

Which Region Has The Greatest Market Share In The Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Endovascular Stent Grafts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Endovascular Stent Grafts Market At The End Of The 2026–2030 Forecast Period?

The endovascular stent grafts market has seen its size increase significantly in recent years. It is forecast to grow from $1.45 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 37.9%. Historically, this expansion has been driven by factors including reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market size is projected to experience substantial growth over the next few years, reaching $7.13 billion in 2030 with a compound annual growth rate (CAGR) of 37.5%. This projected expansion is primarily driven by technological advancements in endovascular stent grafts, an increase in minimally invasive surgeries, a rise in aortic aneurysm and dissection cases, the growing acceptance of hybrid vascular grafts, and the development of cardiovascular healthcare infrastructure. Significant trends anticipated during the forecast period include a greater adoption of minimally invasive endovascular procedures, an escalating demand for customized stent grafts, innovations in hybrid and biologic graft materials, an increase in thoracic and abdominal aortic repair procedures, and an intensified focus on patient safety and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Primary Drivers Are Shaping The Development Of The Endovascular Stent Grafts Market?

The rising occurrence of cardiovascular diseases is projected to stimulate the expansion of the endovascular stent graft market moving forward. Cardiovascular disease, defined as a category of conditions impacting the heart or blood vessels, is seeing increased prevalence due to a combination of lifestyle choices, underlying medical issues, genetic predispositions, and environmental elements. Endovascular stent grafts present a valuable solution for managing cardiovascular diseases, focusing on reducing invasiveness and improving patient results. These grafts serve to reinforce weakened vessel walls, thereby preventing ruptures and mitigating the risk of critical complications. For instance, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, indicated that in 2023, roughly 57,100 adults aged 25 and above experienced acute coronary events, averaging approximately 156 incidents daily. Therefore, the increase in cardiovascular diseases is a key driver for the growth of the endovascular stent grafts market.

What Segment Types Make Up The Endovascular Stent Grafts Market?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Which Market Trends Are Creating New Opportunities In The Endovascular Stent Grafts Market?

Companies operating within the endovascular stent grafts market are prioritizing the creation of novel products, such as thoracic aortic stent-grafts, to bolster the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These innovations seek to enhance patient outcomes and resolve intricate anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized medical instrument utilized in endovascular surgery to address illnesses and conditions of the thoracic aorta—the segment of the aorta situated in the chest—offering a blend of safety, efficacy, and ease for managing thoracic aortic diseases. For instance, in February 2024, Endovastec, a medical device company based in China, unveiled the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and performed its inaugural clinical application in Switzerland. The Hector system signifies a substantial leap forward in endovascular stent graft technology, with its multi-branch configuration allowing for the treatment of complex thoracic aortic conditions by accommodating and safeguarding essential aortic branches, such as the arteries that supply vital organs.

Who Are The Key Players Driving Competition In The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Read the full endovascular stent grafts market report here:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

How Does The Endovascular Stent Grafts Market Perform Across Major Global Regions?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Endovascular Stent Grafts Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Endovascular Stent Grafts Market between 2026 and 2030?

The endovascular stent grafts market has observed rapid expansion in its size over recent years. It is anticipated to expand from $1.45 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 37.9%. The drivers behind this historical growth include reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market is projected to experience rapid expansion in the coming years. This market is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This projected growth is driven by factors such as technological advancements in endovascular stent grafts, an increase in minimally invasive surgical procedures, a rise in aortic aneurysm and dissection incidents, greater uptake of hybrid vascular grafts, and the expansion of cardiovascular healthcare infrastructure. Key trends during this forecast period encompass the growing acceptance of minimally invasive endovascular techniques, heightened demand for personalized stent grafts, progress in hybrid and biologic graft materials, the broader application of thoracic and abdominal aortic repair procedures, and an increased emphasis on patient safety and regulatory adherence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Endovascular Stent Grafts Market?

The rising occurrence of cardiovascular ailments is anticipated to drive the expansion of the endovascular stent graft market in the future. Cardiovascular disease, or CVD, encompasses a category of conditions affecting the heart and blood vessels. This growing incidence of cardiovascular diseases stems from a confluence of lifestyle decisions, existing medical conditions, inherited predispositions, and environmental influences. Endovascular stent grafts present a significant treatment alternative for cardiovascular diseases, emphasizing reduced invasiveness and enhanced patient recovery. By strengthening compromised vessel walls, these stent grafts prevent rupture and mitigate the potential for severe, life-threatening complications. As an illustration, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, stated that in 2023, approximately 57,100 adults aged 25 and above suffered acute coronary events, equating to about 156 daily incidents. Consequently, the surge in cardiovascular diseases is a key factor propelling the expansion of the endovascular stent grafts market.

What Segments Are Included Within The Endovascular Stent Grafts Market?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Which Trends Are Expected To Influence The Endovascular Stent Grafts Market In The Upcoming Years?

Companies operating in the endovascular stent grafts market are primarily focused on developing novel products like the thoracic aortic stent-graft. The goal is to enhance the precision and efficacy of treatment for thoracic aortic aneurysms and dissections, improve patient outcomes, and address complex anatomical challenges through advanced technology and design improvements. A thoracic aortic stent graft is a specialized medical device utilized in endovascular surgery to treat conditions and diseases of the thoracic aorta, the section of the aorta situated in the chest, providing a blend of safety, effectiveness, and convenience for managing thoracic aortic diseases. For instance, in February 2024, Endovastec, a medical device company based in China, unveiled the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its initial clinical application in Switzerland. The Hector system represents a significant progression in endovascular stent graft technology, as its multi-branch design facilitates the treatment of complex thoracic aortic conditions by accommodating and preserving essential branches of the aorta, such as the arteries that supply vital organs.

Who Are The Major Companies Operating In The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Endovascular Stent Grafts Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theEndovascular Stent Grafts Market?

The escalating occurrence of cardiovascular diseases is set to stimulate the expansion of the endovascular stent graft market in the future. Cardiovascular diseases, a class that implicates either the heart or blood vessels, are on an upward trend due to lifestyle choices, medical conditions, genetic factors, and environmental elements. Endovascular stent grafts have proved to be a significant option for cardiovascular disease treatment, focusing on decreasing invasiveness and enhancing patient outcomes. These grafts fortify the fragile vessel wall which prevents rupture and lessens the possibility of severe complications. For example, data from the Australian Institute of Health and Welfare, a government agency in Australia, suggested that certified deaths from coronary heart disease increased from 14,100 in 2021 to 14,900 in 2022. Consequently, a heightened occurrence of cardiovascular diseases propels the endovascular stent grafts market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

#What Growth Opportunities Will Drive the Endovascular Stent Grafts Market’s CAGR Through 2034?

The market size for endovascular stent grafts has seen exponential growth recently. Its size is predicted to rise from $1.05 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 37.8%. This growth during the historic period can be credited to the increasing occurrence of aortic aneurysms, a growing aging population, increased healthcare expenditure in developed regions, the increased number of ambulatory surgical centers, and a rise in the incidence of chronic diseases.

Expectations are high for the endovascular stent grafts market to grow significantly in the coming years. By 2029, predictions show it reaching a value of $5.19 billion, representing a compound annual growth rate (CAGR) of 37.6%. This promising outlook for the forecast period is due to several factors, including the ongoing move towards less invasive procedures, rising cases of vascular diseases like atherosclerosis and pulmonary embolism, advantageous reimbursement policies, expanding hospital numbers, and a rising incidence of diabetes among the younger population. Key trends for the forecast period encompass the incorporation of artificial intelligence, the invention of superior imaging technologies, creation of stent grafts customized to the patient, development of next-generation tissue-engineered vascular grafts, and technological advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20549

What Key Market Trends and Innovations Are Shaping the Future of theEndovascular Stent Grafts Industry?

Leading enterprises in the endovascular stent grafts sector are consistently working on the creation of groundbreaking products like the thoracic aortic stent-graft to improve the accuracy and efficiency of treating thoracic aortic aneurysms and dissections. This aims to enhance patient results and tackle intricate anatomical difficulties using superior technology and refined designs. A thoracic aortic stent graft is an exclusive medical apparatus employed in endovascular surgery to manage diseases and disorders of the thoracic aorta, the aorta segment located in the chest, presenting a mix of safety, efficacy, and comfort in handling thoracic aortic illnesses. For example, Endovastec, a medical device firm based in China, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector), conducting its initial clinical application in Switzerland in February 2024. The Hector system embodies a considerable progression in endovascular stent graft technology, with its multi-branch design facilitating the treatment of intricate thoracic aortic conditions by accommodating and preserving crucial branches of the aorta, such as the arteries that fuel essential organs.

Which Companies Are Leading the Charge in Expanding theEndovascular Stent Grafts Market Growth?

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

How is the Global Endovascular Stent Grafts Market Segemented?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Which Geographics are Influencing the Growth of the Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2025, By The Business Research Company:

Neuroendovascular Coil Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

How has the endovascular stent grafts market grown in recent years?

The market size for endovascular stent grafts has seen exponential growth in the recent past. It’s slated to expand from a valuation of $1.05 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 37.8%. This progression in the historical duration can be tied to the escalating instances of aortic aneurysms, surging elderly population, increased healthcare investments in developed regions, rise in the establishment of ambulatory surgical centres, and an uptick in the prevalence of chronic illness.

How is the endovascular stent grafts market size expected to evolve during the forecast period?

The market for endovascular stent grafts is projected to undergo significant growth in the coming years, soaring to $5.19 billion by 2029 with a compound annual growth rate (CAGR) of 37.6%. Factors driving this growth during the forecast period include a move towards less invasive surgical procedures, a rise in vascular illnesses like atherosclerosis and pulmonary embolism, beneficial reimbursement policies, an increase in the number of hospitals, and an increased prevalence of diabetes among young people. Key trends during this forecast period are expected to be the integration of artificial intelligence, the advancement of imaging technologies, the creation of patient-specific or customizable stent grafts, the development of next-generation tissue-engineered vascular grafts, and overall technological advancements.

Get your endovascular stent grafts market report here!

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

Which key drivers are propelling the endovascular stent grafts market’s growth?

The surge in cardiovascular disease prevalence is anticipated to boost the impact of endovascular stent grafts in the future. Cardiovascular disease is a broad term encompassing conditions affecting the heart and blood vessels. Lifestyle choices, medical conditions, genetic predisposition, and environmental factors contribute to the growth in cardiovascular issues. Endovascular stent grafts provide a beneficial solution aiming to decrease invasiveness and enhance patient results when dealing with cardiovascular diseases. These stent grafts strengthen the compromised vessel wall, lowering the chance of rupture and potentially dangerous complications. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, released data in December 2023 showing that the count of deaths certified by doctors due to coronary heart disease moved up from 14,100 in 2021 to 14,900 in 2022. Consequently, the rise in cardiovascular diseases is fuelling the demand for endovascular stent grafts in the marketplace.

What are the market segments in the endovascular stent grafts industry?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

Which leading companies are shaping the growth of the endovascular stent grafts market?

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

What key trends are currently impacting the endovascular stent grafts market’s development?

Key players in the endovascular stent grafts market are striving towards innovation such as the development of thoracic aortic stent-graft. This development aims to improve precision and effectiveness when treating thoracic aortic aneurysms and dissections, enhance patient results, and overcome intricate anatomical challenges through technology and design advancements. Thoracic aortic stent graft is a particular medical device utilized in endovascular surgery for treating ailments and conditions of the thoracic aorta, a section of the aorta located in the chest. This device offers a blend of safety, efficacy, and convenience for managing diseases of the thoracic aorta. For example, in February 2024, the Chinese medical device firm Endovastec launched its Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and successfully carried out its maiden clinical application in Switzerland. The Hector system marks a significant stride in endovascular stent graft tech. This multi-branch design enables treatment of intricate thoracic aortic conditions by accommodating and preserving crucial branches of the aorta, like arteries that supply essential organs.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20549

Which geographic areas are influencing the growth of the endovascular stent grafts market?

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Neuroendovascular Coil Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Endovascular Stent Grafts Market Over the 2025–2034 Period?

The market size for endovascular stent grafts has seen an exponential increase in past years. It’s anticipated to escalate from $1.05 billion in 2024 to $1.45 billion in 2025, reporting a compound annual growth rate (CAGR) of 37.8%. This growth during the past period is chiefly due to an increase in the prevalence of aortic aneurysms, an aging population, elevated healthcare expenses in developed areas, an upswing in the count of ambulatory surgical centers, and a surge in chronic disease occurrences.

The market size for endovascular stent grafts is forecasted to witness a rapid increase in the upcoming years, rising to a value of $5.19 billion in 2029 with a compound annual growth rate (CAGR) of 37.6%. Several factors contribute to this projected growth, including the persistent shift towards less invasive procedures, a rise in vascular illnesses like atherosclerosis and pulmonary embolism, favorable reimbursement policies, a greater number of hospitals, and an increase in diabetes even in younger demographics. Key market trends expected during the forecast period involve the incorporation of artificial intelligence, the innovation of advanced imaging technologies, the creation of patient-specific or customizable stent grafts, the development of the next gen tissue-engineered vascular grafts, and technological advancements.

What Are the Primary Drivers Supporting the Growth of the Endovascular Stent Grafts Market?

The surge in cardiovascular disease cases is anticipated to fuel the expansion of the endovascular stent graft market. Cardiovascular disease, or CVD, encompasses a variety of conditions affecting the heart or blood vessels. This spike in cardiovascular diseases is the result of a blend of factors including lifestyle choices, medical conditions, genetic factors, and environmental aspects. For treating such diseases, endovascular stent grafts are an important alternative, marking a crucial emphasis on reducing invasiveness and enhancing patient results. These stent grafts reinforce the fragile blood vessel wall, hence preventing it from bursting and lowering the possibility of critical complications. For instance, data from the Australian Institute of Health and Welfare, a government agency in Australia, from December 2023, showed that doctor-verified deaths from coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the rise in cardiovascular diseases is propelling the endovascular stent graft market.

Explore Comprehensive Insights Into The Global Endovascular Stent Grafts Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are:

• Cardinal Health Inc.

• Abbott Laboratories

• Medtronic PLC

• Stryker Corporation

• Becton

What Impact Are Industry Trends Having on the Endovascular Stent Grafts Market’s Future Prospects?

Prominent industry players in the endovascular stent grafts market are concentrating their efforts on the production of innovative goods, including the thoracic aortic stent-graft. The primary aim is to augment the accuracy and effectiveness of thoracic aortic aneurysms and dissections treatment, enhance patient prognoses, and overcome intricate anatomical difficulties through advanced technology and design enhancements. A thoracic aortic stent graft is a unique medical instrument utilized in endovascular surgery to treat diseases and conditions impacting the thoracic aorta. This segment of the aorta, situated within the chest, offers a unique blend of safety, efficiency, and convenience for dealing with thoracic aortic ailments. As an example, in February 2024, Endovastec, a medical device enterprise based in China, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and executed its inaugural clinical application in Switzerland. The Hector system marks a substantial progression in endovascular stent graft technology. It’s multi-branch structure allows for the treatment of intricate thoracic aortic conditions, preserving and accommodating essential aorta branches, including the arteries that cater to indispensable organs.

Secure Your Global Endovascular Stent Grafts Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

How Are the Key Segments of the Endovascular Stent Grafts Market Impacting Its Expansion and Revenue Streams?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

What Regions Are Leading the Growth Trajectory of the Endovascular Stent Grafts Market?

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Endovascular Stent Grafts Market?

Endovascular stent grafts are medical devices used to treat conditions involving blood vessels, such as aneurysms or stenosis. They consist of a metal stent (a small mesh tube) covered with a fabric graft. The stent graft is inserted into the affected blood vessel through a catheter, typically into a large artery in the groin or arm. Endovascular stent grafts often repair aneurysms (dilated areas of blood vessels) or other vessel damage, offering a less invasive alternative to traditional surgery.

Browse Through More Similar Reports By The Business Research Company:

Neuroendovascular Coil Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: